Evidence map›Paper›PMID 40161149›Full record

ArticleCureus2025

Ophthalmic Manifestations Revealing Neurological Relapse in T-cell Acute Lymphoblastic Leukemia: A Case Report.

Loubna Mouhib, Hala Ait Ammar, Mounia Bendari, Mehdi Khamaily, Mohamed Elbelhadji

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Loubna MouhibDepartment of Ophthalmology, Mohammed VI International University Hospital, Mohammed VI University of Sciences and Health (UM6SS), Casablanca, MAR.
Hala Ait AmmarDepartment of Ophthalmology, Mohammed VI International University Hospital, Mohammed VI University of Sciences and Health (UM6SS), Casablanca, MAR.
Mounia BendariDepartment of Hematology, Mohammed VI International University Hospital, Mohammed VI University of Sciences and Health (UM6SS), Casablanca, MAR.
Mehdi KhamailyDepartment of Ophthalmology, Mohammed VI International University Hospital, Mohammed VI University of Sciences and Health (UM6SS), Casablanca, MAR.
Mohamed ElbelhadjiDepartment of Ophthalmology, Mohammed VI International University Hospital, Mohammed VI University of Sciences and Health (UM6SS), Casablanca, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ophthalmic manifestations of acute leukemia are critically important, as ocular involvement may be the sole clinical indicator of the disease or signify a recurrence of leukemia. Ocular manifestations include the orbit, anterior segment, optic nerve, retina, and choroid, with posterior segment involvement being the most prevalent. We report the case of a 19-year-old woman with acute lymphoblastic leukemia (ALL). The patient was in remission after completing the Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) protocol. A decrease in visual acuity revealed an infiltration of the anterior and posterior segments of the patient's eye, indicating a disease relapse. A cerebral magnetic resonance imaging (MRI) showed substantial optic nerve infiltration. A lumbar puncture confirmed the recurrence, with a positive result for leukemia. It was a relapse of ALL, unmasked by the ophthalmic involvement, which prompted a change in disease status and treatment. Ocular involvement can sometimes be the first sign of the disease or its recurrence, making it crucial to recognize and address promptly, as it may precede other serious clinical manifestations. Therefore, it is essential to systematically include an ophthalmological examination in the follow-up of patients with acute leukemia.

Indexed as

chorioretinal infiltrationneurological relapseoptic nerve infiltrationpapilledemat-cell acute lymphoblastic leukemia

Identifiers

PMID40161149
PMCPMC11954442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.